Dosage and administration
Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Aurum muriaticum 6X
Symphytum officinale 6X
Hekla lava 8X
Sarcolacticum acidum 15X
Asterias rubens 30X
Crotalus horridus 30X
Thuja occidentalis 30X
Secale cornutum 60X
Malandrinum 100X
Carcinosin 100X, 200X
Arsenicum album 200X
Petroleum 200X
Sulphur 200X
Professional Formulas
PO Box 2034 Lake Oswego, OR 97035
For the temporary relief of fatigue, insomnia, sinusitis or other upper respiratory allergies, or suppression of emotions consistent with classical carcinosin miasm.*
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
In case of overdose, get medical help or contact a poison control center right away.
Keep out of the reach of children.
If pregnant or breastfeeding, ask a healthcare professional before use.
Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Tamper resistant. If seal is broken, do not use. After opening, close container tightly and store at room temperature away from heat.
20% ethanol, purified water.
Est 1985
Professional Formulas
Complementary Health
Carcinosin Miasm Drops
Homeopathic Remedy
2 FL. OZ. (59 mL)
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 63f39a63-5cd1-4016-bd86-2bbb0f6c3139 | Product name | 3 | 20240506 |
| e5a77e9c-c528-733a-173d-914a234c024b | Product name | 5 | 20240506 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63083-2142-2 | 2026-01-09 | C162847 | 48780-1 | 1030e365-1a81-111a-e063-dadaa90a10e2 | C142 |
| 63083-2142-2 | 2026-01-09 | C162847 | 48780-1 | 1030e365-1a81-111a-e063-dadaa90a10e2 | C142 |
| 63083-2142-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1a81-111a-e063-dadaa90a10e2 | C142 |
| 63083-2142-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1a81-111a-e063-dadaa90a10e2 | C142 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63083-2142-2 | Carcinosin Miasm Drops2142 | 59 mL in 1 BOTTLE, DROPPER | LIQUID | 59 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63083-2142 | 63083-2142-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GOLD TRICHLORIDE | 15443PR153 | ACTIB |
| COMFREY ROOT | M9VVZ08EKQ | ACTIB |
| HEKLA LAVA | C21158IIRK | ACTIB |
| LACTIC ACID, L- | F9S9FFU82N | ACTIB |
| ASTERIAS RUBENS | A7FYY9Q742 | ACTIB |
| CROTALUS HORRIDUS HORRIDUS VENOM | YHA2XLJ956 | ACTIB |
| THUJA OCCIDENTALIS LEAF | 0T0DQN8786 | ACTIB |
| CLAVICEPS PURPUREA SCLEROTIUM | 01G9XEA93N | ACTIB |
| MELANDRIN | C7UC00UZ0I | ACTIB |
| HUMAN BREAST TUMOR CELL | C62OO7VD9K | ACTIB |
| ARSENIC TRIOXIDE | S7V92P67HO | ACTIB |
| LIQUID PETROLEUM | 6ZAE7X688J | ACTIB |
| SULFUR | 70FD1KFU70 | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2019-08-15 | full-release | 2026-06-01 02:16:25 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carcinosin Miasm Drops 2142 | CARCINOSIN MIASM DROPS | Professional Complementary Health Formulas | d6d1c012-1b72-499c-b736-5e0d8e0b0df7 | 2026-01-08 | Warnings | 63083-2142-2 63083-2142 63083214202 64ee9159-2ce5-4e0a-9db6-a0657a1f3691 d6d1c012-1b72-499c-b736-5e0d8e0b0df7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.